According to Kamada 's latest financial reports the company's total liabilities are $0.11 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.11 B | -24.24% |
2022-12-31 | $0.14 B | 3.18% |
2021-12-31 | $0.14 B | 342.89% |
2020-12-31 | $32.02 M | -16.77% |
2019-12-31 | $38.47 M | 49.49% |
2018-12-31 | $25.74 M | -21.09% |
2017-12-31 | $32.61 M | -1.02% |
2016-12-31 | $32.95 M | 11.76% |
2015-12-31 | $29.48 M | -23.86% |
2014-12-31 | $38.72 M | -21.63% |
2013-12-31 | $49.4 M | -18.63% |
2012-12-31 | $60.72 M | -3.27% |
2011-12-31 | $62.77 M | -3.47% |
2010-12-31 | $65.03 M | 99.14% |
2009-12-31 | $32.65 M | 11.01% |
2008-12-31 | $29.41 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | $5.14 B | 4,544.23% | ๐บ๐ธ USA |
Compugen CGEN | $55.77 M | -49.70% | ๐ฎ๐ฑ Israel |